This researcher focuses on developing and validating biomarkers to predict outcomes and guide treatment decisions in prostate cancer, particularly examining ratios such as Prostate-Specific Antigen (PSA) concentration relative to other markers like C-reactive Protein and hemoglobin. Their work contributes to advancing the diagnosis and management of prostate cancer by leveraging these novel biomarkers to improve predictive accuracy and patient care.
This profile is generated from publicly available publication metadata and is intended for research discovery purposes. Themes, summaries, and trajectories are inferred computationally and may not capture the full scope of the lecturer's work. For authoritative information, please refer to the official KNUST profile.